<span item_type="fundamental" item_id="59fbc632a4f4a86679c8da35d3cdbfc5" counter_id="ST/US/REEWF" env="prod"></span><span item_type="announcement" item_id="582646355778211201" env="prod"></span><p>Revenue: As of FY2025 Q3, the actual value is USD 0.</p><p>EPS: As of FY2025 Q3, the actual value is USD 0.03.</p><p>EBIT: As of FY2025 Q3, the actual value is USD -904.43 K.</p><p></p><h3>Segment Revenue</h3><ul><li>Cartesian Growth Corporation II has not commenced any operations and does not generate operating revenues until after the completion of its initial Business Combination.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1889112/000110465925111663/tmb-20250930x10q.htm"></span></li></ul><h3>Operational Metrics</h3><ul><li>For the three months ended September 30, 2025, the company reported net income of $338,160, compared to $2,909,414 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1889112/000110465925111663/tmb-20250930x10q.htm"></span></li><li>Operating costs for the three months ended September 30, 2025 were $203,228, compared to $217,022 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1889112/000110465925111663/tmb-20250930x10q.htm"></span></li><li>For the nine months ended September 30, 2025, net income was $745,793, compared to $7,551,693 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1889112/000110465925111663/tmb-20250930x10q.htm"></span></li><li>Operating costs for the nine months ended September 30, 2025 were $660,860, compared to $638,503 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1889112/000110465925111663/tmb-20250930x10q.htm"></span></li></ul><h3>Cash Flow</h3><ul><li>Net cash used in operating activities for the nine months ended September 30, 2025 was $442,577, compared to $351,168 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1889112/000110465925111663/tmb-20250930x10q.htm"></span></li><li>Net cash used in investing activities for the nine months ended September 30, 2025 was - $1,850,000, compared to - $1,350,000 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1889112/000110465925111663/tmb-20250930x10q.htm"></span></li><li>Net cash provided by financing activities for the nine months ended September 30, 2025 was $2,100,000, compared to $1,850,000 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1889112/000110465925111663/tmb-20250930x10q.htm"></span></li></ul><h3>Unique Metrics</h3><ul><li>Interest earned on cash and marketable securities held in the Trust Account for the three months ended September 30, 2025 was $701,198, compared to $2,340,228 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1889112/000110465925111663/tmb-20250930x10q.htm"></span></li><li>Interest earned for the nine months ended September 30, 2025 was $2,063,025, compared to $6,924,394 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1889112/000110465925111663/tmb-20250930x10q.htm"></span></li></ul><h3>Future Outlook and Strategy</h3><ul><li>The company has extended the date by which it has to consummate a business combination to August 5, 2026, following shareholder approval of the Third Extension Charter Amendment.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1889112/000110465925111663/tmb-20250930x10q.htm"></span></li><li>The company intends to effectuate its initial business combination using cash from the net proceeds of its initial public offering, the sale of private placement warrants, the sponsor loan, its share capital, or a combination of cash, share capital, and debt.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1889112/000110465925111663/tmb-20250930x10q.htm"></span></li><li>The company expects to incur significant costs in the pursuit of its acquisition plans and cannot assure that its plans to complete an initial business combination will be successful.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1889112/000110465925111663/tmb-20250930x10q.htm"></span></li></ul>

CARTESIAN GROWTH CORPORATION II C/WTS 12/07/2028 (TO PUR COM CL A) | 10-Q: FY2025 Q3 Revenue: USD 0